There are 2789 resources available
1114P - Comparative study of combined large cell neuroendocrine carcinoma and combined small cell carcinoma in resected high-grade neuroendocrine tumors of the lung
Presenter: Yanan Wang
Session: ePoster Display
1064P - Final results of CA209-9JC: A phase II study of first-line nivolumab in patients with advanced cutaneous squamous cell carcinoma
Presenter: Rodrigo Ramella Munhoz
Session: ePoster Display
1065P - A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission
Presenter: Salvatore Alfieri
Session: ePoster Display
1066P - Extended-dose cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Primary analysis of phase II results
Presenter: Danny Rischin
Session: ePoster Display
1067P - Correlation between the number of risk factors and relapse in patients with cutaneous squamous cell carcinoma: A predictive factor for accurate adjuvant radiotherapy?
Presenter: Adeline Petre
Session: ePoster Display
1068P - Efficacy of combined hypo-fractionated radiotherapy (RT) in anti-PD-1 monotherapy-treated melanoma pts
Presenter: Philippe Saiag
Session: ePoster Display
1075P - Regression tree analysis to identify factors associated with relapse-free survival (RFS) in patients with resected stage III BRAF V600E/K–mutant melanoma
Presenter: Caroline Robert
Session: ePoster Display
1076P - Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
Presenter: Mehmet Alpaslan Ozgun
Session: ePoster Display
1077P - Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) undergoing systemic therapy: A systematic literature review (SLR) and meta-analysis (MA) of real-world evidence (RWE)
Presenter: Georgina Long
Session: ePoster Display